94.99

0.29% 0.27

After Hours: 94.99

Cvs Health Corp (CVS)

Overview News Price History Option Chain Financials Why CVS Down? Discussions Forecast Stock Split Dividend History

Cvs Health Corp stock is traded at $94.99, with a volume of 6.45M. It is up +0.29% in the last 24 hours and down -10.30% over the past month. CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.

Previous Close:

$94.72

Open:

$95.44

24h Volume:

6.45M

Relative Volume:

0.79

Market Cap:

$121.49B

Revenue:

$407.94B

Net Income/Loss:

$2.90B

P/E Ratio:

41.72

EPS:

2.2771

Net Cash Flow:

$7.39B

1W Performance:

-1.28%

1M Performance:

-10.30%

6M Performance:

+21.04%

1Y Performance:

+44.14%

1-Day Range:

$94.48

$96.12

1-Week Range:

$93.01

$96.36

52-Week Range:

$66.24

$110.68

Cvs Health Corp Stock (CVS) Company Profile

Name

Cvs Health Corp

Sector

Healthcare (1075)

Industry

Healthcare Plans (14)

Phone

(401) 765-1500

Address

ONE CVS DR., WOONSOCKET

Employee

300,000

Twitter

@cvshealth

Next Earnings Date

2026-08-05

Latest SEC Filings

CVS's Discussions on Twitter

Compare CVS vs UNH, ELV, CI, HUM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CVS Cvs Health Corp	94.99	121.14B	407.94B	2.90B	7.39B	2.2771
UNH Unitedhealth Group Inc	399.06	364.06B	450.13B	14.91B	23.62B	15.55
ELV Elevance Health Inc	398.22	86.56B	201.11B	4.95B	6.29B	22.50
CI Cigna Group	277.99	73.30B	278.13B	6.74B	7.66B	23.60
HUM Humana Inc	384.97	46.69B	137.20B	1.15B	1.27B	9.3439

Cvs Health Corp Stock (CVS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-12-26	Upgrade	Bernstein	Mkt Perform → Outperform
Oct-14-25	Initiated	Goldman	Buy
Aug-18-25	Upgrade	UBS	Neutral → Buy
Aug-14-25	Upgrade	Robert W. Baird	Neutral → Outperform
Feb-13-25	Upgrade	Leerink Partners	Market Perform → Outperform
Feb-12-25	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Jan-30-25	Upgrade	Edward Jones	Hold → Buy
Dec-03-24	Upgrade	Deutsche Bank	Hold → Buy
Nov-18-24	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-10-24	Upgrade	Barclays	Equal Weight → Overweight
Oct-04-24	Upgrade	TD Cowen	Hold → Buy
May-30-24	Initiated	Robert W. Baird	Neutral
May-07-24	Downgrade	TD Cowen	Buy → Hold
May-02-24	Downgrade	UBS	Buy → Neutral
May-01-24	Downgrade	Cantor Fitzgerald	Overweight → Neutral
May-01-24	Downgrade	Leerink Partners	Outperform → Market Perform
Mar-06-24	Initiated	Barclays	Equal Weight
Feb-26-24	Initiated	Leerink Partners	Outperform
Dec-22-23	Initiated	HSBC Securities	Buy
Sep-19-23	Upgrade	Evercore ISI	In-line → Outperform
Sep-12-23	Upgrade	Wolfe Research	Peer Perform → Outperform
Aug-18-23	Downgrade	Edward Jones	Buy → Hold
May-26-23	Initiated	Piper Sandler	Overweight
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line
Nov-23-22	Resumed	Morgan Stanley	Overweight
Jun-17-22	Initiated	Loop Capital	Buy
May-27-22	Downgrade	Bernstein	Outperform → Mkt Perform
Mar-29-22	Downgrade	Deutsche Bank	Buy → Hold
Feb-11-22	Downgrade	Raymond James	Strong Buy → Outperform
Dec-14-21	Initiated	Goldman	Buy
Dec-01-21	Initiated	Seaport Research Partners	Buy
May-19-21	Initiated	Wells Fargo	Equal Weight
Mar-17-21	Downgrade	Guggenheim	Buy → Neutral
Jan-08-21	Upgrade	Jefferies	Hold → Buy
Sep-17-20	Initiated	Piper Sandler	Overweight
Jul-01-20	Initiated	SVB Leerink	Mkt Perform
May-14-20	Upgrade	Credit Suisse	Neutral → Outperform
Sep-27-19	Resumed	RBC Capital Mkts	Outperform
Sep-12-19	Initiated	Deutsche Bank	Buy
Jun-05-19	Upgrade	Standpoint Research	Hold → Buy
Apr-29-19	Downgrade	Credit Suisse	Outperform → Neutral
Apr-18-19	Initiated	Guggenheim	Buy
Apr-15-19	Downgrade	Oppenheimer	Outperform → Perform
Apr-10-19	Reiterated	BofA/Merrill	Buy
Mar-13-19	Initiated	Bernstein	Outperform
Feb-20-19	Downgrade	Wells Fargo	Outperform → Market Perform
Jan-17-19	Initiated	UBS	Buy
Dec-18-18	Initiated	Barclays	Overweight
Nov-29-18	Resumed	Goldman	Neutral
Nov-28-18	Initiated	Evercore ISI	Outperform
Oct-26-18	Resumed	Wolfe Research	Peer Perform
Jul-09-18	Upgrade	Citigroup	Neutral → Buy
Feb-27-18	Resumed	BofA/Merrill	Buy
Feb-13-18	Reiterated	Citigroup	Neutral

View All

Cvs Health Corp Stock (CVS) Latest News

Aug 13, 2026

Dodge & Cox (CVS: CVS) reports 50M-share, 3.9% ownership stake in CVS Health - Stock Titan

Aug 13, 2026

CVS Health Enhances Its Direct-to-Consumer Weight Management Offerings To Improve Access, Affordability, Care and Support for GLP-1 Medications - Yahoo Finance

Aug 13, 2026

CVS Health (CVS) Stock Trades Below Fair Value After A 48% Gain - simplywall.st

Aug 13, 2026

Employer Survey Signals Coming Shakeup in PBM Market Dynamics - Bloomberg Law News

Aug 13, 2026

Aug 12, 2026

CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch

Aug 12, 2026

CVS Maintains Overweight Rating by JP Morgan -- Price Target Rai - GuruFocus

Aug 12, 2026

JPMorgan Chase & Co. Issues Positive Forecast for CVS Health (NYSE:CVS) Stock Price - MarketBeat

Aug 12, 2026

CVS Caremark study shows employers rely on PBM expertise - CVS Health

Aug 12, 2026

CVS Caremark Survey: 80% of Employers Limit or Consider GLP-1 Limits - Stock Titan

Aug 12, 2026

Wedge Capital Management L L P NC Has $31.23 Million Position in CVS Health Corporation $CVS - MarketBeat

Aug 12, 2026

E. Ohman J or Asset Management AB Decreases Holdings in CVS Health Corporation $CVS - MarketBeat

Aug 12, 2026

Aug 11, 2026

AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance

Aug 11, 2026

CVS Health Corp. stock underperforms Tuesday when compared to competitors - MarketWatch

Aug 11, 2026

AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Aug 11, 2026

News by ACCESS Newswire on TradingView, 2026-08-11 - TradingView

Aug 11, 2026

Handelsbanken Fonder AB Buys 496,124 Shares of CVS Health Corporation $CVS - MarketBeat

Aug 11, 2026

Aug 10, 2026

Elizabeth Warren Says UnitedHealth, CVS Have Too Much Control Over US Healthcare—Now She Wants to Break Up the Vertical Integration - Yahoo Finance

Aug 10, 2026

CVS Health: I Wanted A Beat And Raise, I Got It, And I'm Still At 'Hold' (NYSE:CVS) - Seeking Alpha

Aug 10, 2026

Elizabeth Warren Vows to Break the Monopoly of UnitedHealth Group, CVS Health and Cigna: 'I Have a Bill t - Benzinga

Aug 10, 2026

Vertrix Wealth Management LLC Invests $3.79 Million in CVS Health Corporation $CVS - MarketBeat

Aug 10, 2026

NewEdge Advisors LLC Grows Stake in CVS Health Corporation $CVS - MarketBeat

Aug 10, 2026

Aug 09, 2026

Oliver Luxxe Assets LLC Boosts Holdings in CVS Health Corporation $CVS - MarketBeat

Aug 09, 2026

Aug 08, 2026

CVS Health (NYSE:CVS) Upgraded at Wall Street Zen - MarketBeat

Aug 08, 2026

Aug 07, 2026

CVS Health explained: pharmacy, insurance, and health services - qz.com

Aug 07, 2026

CVS pharmacy workers in Rhode Island stage walkout over staffing levels - The Business Journals

Aug 07, 2026

CVS Health Corporation $CVS Shares Acquired by Assenagon Asset Management S.A. - MarketBeat

Aug 07, 2026

Czech National Bank Raises Stake in CVS Health Corporation $CVS - MarketBeat

Aug 07, 2026